Loading clinical trials...
Loading clinical trials...
1. To better understand the factors that contribute to ROM abnormalities in children diagnosed with CP. 2. To describe the distribution of primary (muscle tone and postural stability)and secondary impairments (ROM and functional muscle strength) across the gross motor spectrum measured by GMFCS scores. 3. To evaluate the effects of primary and secondary impairments on gross functional outcome in children with spastic CP. 4. To find any possible correlation between clinical variables.
Age
1 - 5 years
Sex
ALL
Healthy Volunteers
No
Faculty of Physical Therapy Cairo University
Cairo, Cairo Governorate, Egypt
Start Date
August 1, 2024
Primary Completion Date
January 1, 2025
Completion Date
February 1, 2025
Last Updated
October 1, 2024
120
ESTIMATED participants
balance and range of motion
DIAGNOSTIC_TEST
Lead Sponsor
Cairo University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07168577